Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Morie A GertzPublished in: American journal of hematology (2022)
Delayed diagnosis remains a major obstacle to initiating effective therapy prior to the development of end-stage organ failure. Trials of antibodies to catabolize deposited fibrils are underway.